Stay updated on Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:29:59.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government funding lapse notice and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T14:09:12.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide funding/operational notice was added and the page revision tag updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:15:14.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Cosmetic UI and footer metadata updates were made: the glossary toggle label was added, capitalization tweaks in labels, and a new revision/version line in the footer; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:45:12.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:26:05.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The Locations section was reorganized under a centralized Locations block, with Georgia, New York, and Pennsylvania added as subsections and the separate state location blocks removed. The HHS Vulnerability Disclosure link was removed and the revision updated to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T17:21:32.000Z thumbnail image

Stay in the know with updates to Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial page.